---
title: "Hvsen Biotech: \"Four Seasons Green Extract Powder\" has obtained a new veterinary drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244018517.md"
description: "Hvsen Biotech announced that its subsidiary Hubei Hvsen Biotechnology Co., Ltd. has jointly applied for and obtained the new veterinary drug registration certificate for \"Four Seasons Green Extract Powder,\" which was issued by the Ministry of Agriculture and Rural Affairs on June 9, 2025. The acquisition of this certificate reflects the company's continuous efforts in technological innovation and R&D investment, enriches the variety of traditional Chinese medicine products, meets the requirements for green animal-derived food and animal disease prevention, and enhances market competitiveness"
datetime: "2025-06-11T07:48:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244018517.md)
  - [en](https://longbridge.com/en/news/244018517.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244018517.md)
---

# Hvsen Biotech: "Four Seasons Green Extract Powder" has obtained a new veterinary drug registration certificate

According to the announcement from Zhitong Finance APP, Hvsen Biotech (300871.SZ) has released a notice stating that, in accordance with the "Regulations on Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs," the Ministry of Agriculture and Rural Affairs of the People's Republic of China (hereinafter referred to as "the Ministry") has reviewed and approved the new veterinary drug "Four Seasons Green Extract Powder," jointly applied for by the company's subsidiary Hubei Hvsen Biotech Co., Ltd. and other units. The Ministry issued the "New Veterinary Drug Registration Certificate" (Announcement No. 917 of the Ministry) on June 9, 2025.

The acquisition of this new veterinary drug certificate reflects the company's continuous emphasis on technological innovation and increased investment in research and development, further enriching the company's range of traditional Chinese medicine products. The development and application of this product meet the development requirements for green animal-derived food and animal disease prevention and treatment medications. The product has good stability and is convenient to use, aligning with the direction of modernization of traditional Chinese medicine, and can be used in commercial feed and breeding processes, which is beneficial for further enhancing the company's market competitiveness

### Related Stocks

- [300871.CN](https://longbridge.com/en/quote/300871.CN.md)
- [562390.CN](https://longbridge.com/en/quote/562390.CN.md)

## Related News & Research

- [01:00 ET"Greatest Tomatoes from Europe" Returns to the USA to Celebrate the Quality, Heritage, and Versatility of European and Italian Canned Tomatoes](https://longbridge.com/en/news/287007471.md)
- [ZAWYA: VIDEO: Dubai-based eyewear firm Magrabi Retail to acquire 51% stake in Egypt’s Baraka Optics](https://longbridge.com/en/news/286881451.md)
- [TECHNICALS-CBOT soybeans may extend gains into $12.13-1/2 to $12.17-1/4 range](https://longbridge.com/en/news/287016093.md)
- [ZAWYA: GlobalCorp secures Egypt’s largest mortgage securitization at $62mln](https://longbridge.com/en/news/286715027.md)
- [Australia secures more jet fuel from China, urea from Brunei](https://longbridge.com/en/news/286838771.md)